EVIDENCE FOR THE ROLE OF CR-1 (CD35), IN ADDITION TO CR-2 (CD21), IN FACILITATING INFECTION OF HUMAN T-CELLS WITH OPSONIZED HIV

Complement activation by HIV results in the binding of C3 fragments to the gp160 complex and enhanced infection of C3 receptor-bearing targe t cells. We have studied complement-mediated enhancement of infection of the human CD4-positive T-cell line HPB-ALL which expresses the CR1 (CD35) and CR2 (CD21) receptors for C3. CRI and CR2 are present on 15% and 40% of normal peripheral blood CD4-positive T lymphocytes respect ively. Opsonization of the virus with complement resulted in a 3- to 1 0-fold enhancement of infection of HPB-ALL cells, as assessed by measu ring the release of p24 antigen in culture supernatants throughout the culture period. Blockade of CR2 with cross-linked anti-CR2 monoclonal antibodies decreased infection to the level observed with unopsonized virus. Blocking CRI reduced complement-mediated infection by 50-80%. Experiments using serum deficient in complement factor I demonstrated that CRI mediates the interaction between opsonized virus and T cells in addition to its ability to serve as a cofactor for the cleavage of C3b into smaller fragments that interact with CR2. A requirement for C D4 in complement-mediated enhancement of infection was observed with H IV-1 Bru but not with HIV-I RF. Thus, CR1 and CR2 contribute in an ind ependent and complementary fashion to penetration of opsonized virus i nto complement receptor-expressing T cells. Involvement of CD4 in infe ction with opsonized virus depends on the viral strain.